Open label, 2-period cross-over, randomised, pilot food effect study to provide preliminary information on the effect of a high-fat meal on the pharmacokinetics (PK) of a single-dose oral administration of ZY-19489 in health volunteers
Latest Information Update: 14 Jun 2022
At a glance
- Drugs ZY 19489 (Primary)
- Indications Malaria
- Focus Adverse reactions; First in man
- Sponsors Cadila Healthcare
- 01 Jun 2022 Results published in The Lancet Infectious Diseases
- 06 May 2021 New trial record